Faculty Information - Shinsuke Saisho

（Last updated : 2024-11-11 11:53:29）

Shinsuke Saisho
Department Kawasaki Medical School Kawasaki Medical School, Department of General Thoracic Surgery,

Position Assistant Professor

■ Journal

1.	2024/04/08	Factors associated with non-completion of palliative radiotherapy for spinal metastasis in patients with terminal cancer: a retrospective study.
2.	2023/11/01	INFORMED CONSENT IN SURGERY FOR PRIMARY LUNG CANCER
3.	2021/12/07	A case of primary aortic sarcoma with tumor infarction after stent graft placement
4.	2021/11	Tumor PD-L1 and VEGF Expression, and CD8 T Cell Infiltration Predict Clinical Response to Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
5.	2021/08/06	The biological Characteristics of Solid Components are Different between Part-Solid-Type and Solid-Type in Lung Adenocarcinoma
6.	2021/05/24	Pulmonary Resection of the Primary Tumor for Patients with Stage IV Non-Small-Cell Lung Cancer
7.	2021/01/24	Tofacitinib overcomes an IFNγ‐induced decrease in NK cell‐mediated cytotoxicity via the regulation of immune‐related molecules in LC‐2/ad
8.	2020/09/01	Perioperative Therapy for Non-Small Cell Lung Cancer - Current Status and Future Perspective -
9.	2019/11/26	Clinicopathological relevance of tumor expression of NK group 2 member D ligands in resected non-small cell lung cancer
10.	2019/08	Effect of platinum-based chemotherapy on the expression of natural killer group 2 member D ligands, programmed cell death-1 ligand 1 and HLA class I in non-small cell lung cancer
11.	2019/05	Comparative study of the PD-L1 expression and CD8+ tumor-infiltrating lymphocyte between surgically resected and matched re-biopsy specimens in recurrent non-small cell lung cancer
12.	2018/10	Deciduoid type malignant pleural mesothelioma: a case report
13.	2018/08	Impact of COX2 Inhibitor for Regulation of PD-L1 Expressioin in Non-small Cell Lung Cancer
14.	2017/10	Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma.
15.	2017/08	Urinary levels of prostaglandin E2 are positively correlated with intratumoral infiltration of Foxp3+ regulatory T cells in non-small cell lung cancer.
16.	2017/07	PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer.
17.	2016/12	Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings
18.	2016/06	Pneumatosis intestinalis after gefitinib therapy for pulmonary adenocarcinoma: a case report.
19.	2016/03	MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small-cell lung cancer
20.	2015/12	Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells.
21.	2015/10	Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells
22.	2015/09	Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer
23.	2015/09	Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small cell lung cancer
24.	2015/08	Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer.
25.	2015/02	Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy.
26.	2015/01	Cyclooxygenase-2 genetic variants influence intratumoral infiltration of Foxp3-positive regulatory T cells in non-small cell lung cancer.
27.	2014/11	Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma.
28.	2014/04	A case report of intrapulmonary schwannoma.
29.	2014	Clinical significance of vascular endothelial growth factor and Delta-like ligand 4 in small pulmonary adenocarcinoma
30.	2013/11	Case of pleural metastasis of prostate cancer.
31.	2013/11	Heterogeneity of the EGFR mutation status between the primary tumor and metastatic lymph node and the sensitivity to EGFR tyrosine kinase inhibitor in non-small cell lung cancer
32.	2013/09	Unknown primary large cell neuroendocrine carcinoma (LCNEC) in the mediastinum.
33.	2013/07	Role of 2-[18F]Fluoro-2-deoxyglucose positron emission tomography in Preoperative Management of Solid-Type Small-Sized Lung Cancer
34.	2013/02	Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy
35.	2013/01	Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis
36.	2013	CT, MRI, and 18F-FDG PET-CT findings of pulmonary benign metastasizing leiomyoma: A case report
37.	2012/12	Current status of Radiologic Diagnosis for Mediastinal Lymph Node Metastases of Non-Small-Cell Lung Cancer: Retrospective Study of pN2 Cases
38.	2012/12	Successful Two-Stage Surgical Treatment for Lung Cancer in a Patient with Contralateral Giant Emphysematous Bullae
39.	2012/09	Characteristics of Non-Small Cell Lung Cancer Located in the Right Middle Lobe According to a Retrospective Study of Recurrence and Prognosis
40.	2012/07	Membrane-bound Estrogen Receptor-alpha Expression and Epidermal Growth Factor Receptor Mutation are Associated with a Poor Prognosis in Lung Adenocarcinoma Patients
41.	2012/02	Maximal Standardized Uptake Value on FDG-PET Is Correlated With Cyclooxygenase-2 Expression in Patients With Lung Adenocarcinoma
42.	2011/12	A clinicopathological and immunohistological re-evaluation of adenosquamous carcinoma of the lung
43.	2011/10	Interstitial lung disease after re-administration of gefitinib in a responder with no adverse effects during the first administration: a case report
44.	2011/08	Disseminated calcifying tumor of the pleura; review of the literature and a case report with immmunohistochemical study of its histogenesis.
45.	2009/01	Evaluation of video-assisted thoracoscopic surgery for pulmonary metastases: 11-years of experience
Display 5 items
Display all(45)

■ Presentation

1.	2023/10/20	Feasibility of Sublobar Resection for Small-Sized Peripheral Stage IA Squamous Cell Carcinoma （Speech，General）
2.	2023/04/27	Informed Consent in Surgery for Primary Lung Cancer （Speech，Panelist at Symposium/Workshop (Applied)）
3.	2022/04/15	Conversion or salvage surgery for patients with unresectable stage III non-small-cell lung cancer （Speech，Panelist at Symposium/Workshop (Applied)）
4.	2021/11/01	Analysis of long-term outcomes after surgical resection in patients with non-small-cell lung cancer （Speech，General）
5.	2019/09/28	JAK-STAT inhibitor overcomes interferon g-reduced, NK cell-mediated cytotoxicity in non-small-cell lung cancer cells. （Poster notice，General）
6.	2019/04/20	Clinical effectiveness of perioperative multi-disciplinary team management for lung cancer surgery （Speech，Panelist at Symposium/Workshop (Applied)）
7.	2018/12/08	3D-complete VATS curative resection for NSCLC （Speech，General）
8.	2018/10/04	Analysis of intraoperative critical situations in thoracoscopic surgery for NSCLC （Poster notice，General）
9.	2018/09/25	Adjuvant chemotherapy is effective for completely resected stage IB non-small cell lung cancer （Poster notice，General）
10.	2018/04/07	Local treatment for patients with oligometastatic non-small-cell lung cancer （Speech，General）
11.	2017/10/17	Prognostic Value of Cox-2 Expression Differs Depending on Tummor CD8+ T Lymphocytes and PD-L1 Expression in Resected Lung Adenocarcinoma. （Poster notice，General）
12.	2017/10/17	Relationship between PD-L1 expression and EGFR/HER2 signaling in non-small-cell lung cancer （Poster notice，General）
13.	2017/09/28	Induction Therapy followed by Surgery for Borderline Resectable cN2 NSCLC （Poster notice，General）
14.	2017/09/11	Survival of non-small cell lung cancer patients predicted from expression of PD-L1, HLA class I and MICA/B on tumor cells （Poster notice，General）
15.	2016/12/07	Comparison of Clinicopathological and Immunohistochemical features in Lung Invasive Mucinous Adenocarcinomaaccording to Computed Tomography Findings. （Poster notice，General）
16.	2016/10/10	Repeated exposure to cisplatin enhances NK cell-mediated cytotoxicity via up-regulation of NKG2D ligands in non-small cell lung cancer cells （Poster notice，General）
17.	2015/12/19	Overexpression of NK cell-activating ligand MICA/B correlates with superior outcomes and might be a therapeutic target for chemo-immunotherapy in non-small-cell lung cancer. （Poster notice，General）
18.	2015/10/19	Evaluation of Novel Electronic Chest Drainage System after Anatomical Pulmonary Resection （Speech，General）
19.	2015/09/28	Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity by upregulating HER2 in malignant pleural mesothelioma cells （Poster notice，General）
20.	2015/09/07	COX-2 Genetic Variants Influence Intratumoral Infiltration of Foxp-3-Positive Regulatory T Cells in Non-Small Cell Lung Cancer （Poster notice，General）
21.	2015/07/25	The effects of pre-clinical clerkship lectures by Essential Medical Skill Ed ucation Team （Speech，General）
22.	2015/07/24	Attempt of medical education using a high-performance simulator at Kawasaki Medical School and affiliated hospital （Speech，General）
23.	2015/04/17	Challenge to Conversion Surgery for Locally Advanced Non-Small Cell Lung Cancer （Speech，General）
24.	2014/10/01	Current state of induction therapy followed by surgery for locally advanced NSCLC （Poster notice，General）
25.	2014/09/28	Cytotoxic anticancer drug enhances NK cell-mediated cytotoxicity via the DNA stress induced NKG2D ligands in non-small-cell lung cancer cells （Poster notice，General）
26.	2014/07/18	Attempt of medical education using a high-performance simulator at Kawasaki Medical School （Speech，General）
27.	2014/07/18	Cytotoxic drugs and EGFR tyrosine kinase inhibitor effect on NK cell cytotoxicity in non-small-cell lung cancer cells （Poster notice，General）
28.	2013/10/30	EGFR signaling effects on NK cell-mediated cytotoxicity via NKG2D ligands-NKG2D interaction in non-small cell lung cancer cells （Speech，General）
29.	2013/10/17	Perioperative management of anticoagulant and antiplatelet therapy for radical surgery of lung cancer （Speech，General）
30.	2013/09/28	Anticancer drugs effect on NK cell-mediated cytotoxicity via the regulation of NKG2D ligand expression in non-small cell lung cancer cells （Poster notice，General）
31.	2013/04/11	Post-recurrence survival and prognostic factors in completely resected non-small cell lung cancer （Poster notice，General）
32.	2012/09/30	HER signaling effects on the NK cell-mediated cytotoxicity via regulation of MHC class I-related chain A/ B in cancer cells （Poster notice，General）
33.	2011/10/12	Biomarker Expression of Primary Non-small Cell Lung Cancer and Metastatic Lympn Nodes （Speech，General）
Display 5 items
Display all(33)

■ Belonging society

1.	1999/06～	Japan Sugucal Society
2.	1999/06～	The Japanese Association for Chest Surgery
3.	2002～	The Japan Lung Cancer Society
4.	2003～	Japan Society for Endoscopic Surgery
5.	2024/01～	Japan Association for Clinical Ethics
6.	2022/10～	Japan Society of Clinical Safety
Display 5 items
Display all(6)